Study supports PSA screening for male BRCA2 carrier

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of theBRCA2mutation, which is associated with a higher incidence of prostate cancer, yo

Updated on: May 25,2024

Study supports PSA screening for male BRCA2 carrier

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of theBRCA2mutation, which is associated with a higher incidence of prostate cancer, yo

Updated on:May 25,2024

Polyploidy study reveals why some cancers are resistant to therapeutic drugs

byOsaka UniversityOverview of the study. (A) We created unique cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage. (B) After trea

Updated on: November 09,2024

Polyploidy study reveals why some cancers are resistant to therapeutic drugs

byOsaka UniversityOverview of the study. (A) We created unique cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage. (B) After trea

Updated on:November 09,2024

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on: February 01,2024

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on:February 01,2024

Bioengineered antibodies target mutant HER2 proteins

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainFor some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and

Updated on: November 10,2024

Bioengineered antibodies target mutant HER2 proteins

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainFor some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and

Updated on:November 10,2024

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on: January 23,2024

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on:January 23,2024

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,

Updated on: January 23,2024

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,

Updated on:January 23,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on: May 09,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on:May 09,2024

Young cancer survivors in Europe get increased post-cure help

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageAs medical advances in oncology enable more patients to beat tumors, greater attention is being paid t

Updated on: February 03,2024

Young cancer survivors in Europe get increased post-cure help

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageAs medical advances in oncology enable more patients to beat tumors, greater attention is being paid t

Updated on:February 03,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct

Updated on: January 30,2024

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct

Updated on:January 30,2024

New cancer 'tracer' promises to detect more tumors earlier

by Ramona Czakert Franson,University of AlbertaCredit: Pixabay/CC0 Public DomainFor people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to res

Updated on: January 11,2024

New cancer 'tracer' promises to detect more tumors earlier

by Ramona Czakert Franson,University of AlbertaCredit: Pixabay/CC0 Public DomainFor people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to res

Updated on:January 11,2024

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on: April 06,2024

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on:April 06,2024